AUD 0.07
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 15.54 Million AUD | -29.28% |
2023 | 21.98 Million AUD | -11.54% |
2022 | 24.85 Million AUD | -8.12% |
2021 | 27.05 Million AUD | 336.19% |
2020 | 6.2 Million AUD | -27.56% |
2019 | 8.56 Million AUD | -7.37% |
2018 | 9.24 Million AUD | 11.54% |
2017 | 8.28 Million AUD | -6.13% |
2016 | 8.82 Million AUD | 46.67% |
2015 | 6.01 Million AUD | -21.14% |
2014 | 7.63 Million AUD | 202.07% |
2013 | 2.52 Million AUD | -30.55% |
2012 | 3.63 Million AUD | 36.77% |
2011 | 2.66 Million AUD | -29.96% |
2010 | 3.79 Million AUD | 670.42% |
2009 | 493.02 Thousand AUD | -74.05% |
2008 | 1.89 Million AUD | -42.36% |
2007 | 3.29 Million AUD | -50.25% |
2006 | 6.62 Million AUD | -17.75% |
2005 | 8.05 Million AUD | 64.06% |
2004 | 4.9 Million AUD | 0.0% |
2002 | 6.57 Million AUD | -16.02% |
2001 | 7.83 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 FY | 15.54 Million AUD | -29.28% |
2024 Q2 | 19.88 Million AUD | 0.0% |
2024 Q4 | 15.54 Million AUD | 0.0% |
2023 FY | 21.98 Million AUD | -11.54% |
2023 Q2 | 23.1 Million AUD | 0.0% |
2023 Q4 | 21.98 Million AUD | 0.0% |
2022 Q4 | 24.85 Million AUD | 0.0% |
2022 FY | 24.85 Million AUD | -8.12% |
2022 Q2 | 25.37 Million AUD | 0.0% |
2021 FY | 27.05 Million AUD | 336.19% |
2021 Q4 | 27.05 Million AUD | 0.0% |
2021 Q2 | 29.06 Million AUD | 0.0% |
2020 FY | 6.2 Million AUD | -27.56% |
2020 Q4 | 6.2 Million AUD | 0.0% |
2020 Q2 | 8.37 Million AUD | 0.0% |
2019 Q4 | 8.56 Million AUD | 0.0% |
2019 FY | 8.56 Million AUD | -7.37% |
2019 Q2 | 7.69 Million AUD | 0.0% |
2018 Q4 | 9.24 Million AUD | 0.0% |
2018 FY | 9.24 Million AUD | 11.54% |
2018 Q2 | 6.15 Million AUD | 0.0% |
2017 Q4 | 8.28 Million AUD | 0.0% |
2017 FY | 8.28 Million AUD | -6.13% |
2017 Q2 | 5.85 Million AUD | 0.0% |
2016 FY | 8.82 Million AUD | 46.67% |
2016 Q2 | 4.14 Million AUD | 0.0% |
2016 Q4 | 8.82 Million AUD | 0.0% |
2015 Q4 | 6.01 Million AUD | 0.0% |
2015 Q2 | 6.49 Million AUD | 0.0% |
2015 FY | 6.01 Million AUD | -21.14% |
2014 FY | 7.63 Million AUD | 202.07% |
2014 Q4 | 7.63 Million AUD | 0.0% |
2014 Q2 | 1.13 Million AUD | 0.0% |
2013 Q4 | 2.52 Million AUD | 0.0% |
2013 FY | 2.52 Million AUD | -30.55% |
2013 Q3 | 2.52 Million AUD | 24.52% |
2013 Q2 | 2.02 Million AUD | 0.0% |
2013 Q1 | 2.02 Million AUD | -44.23% |
2012 Q4 | 3.63 Million AUD | 0.0% |
2012 FY | 3.63 Million AUD | 36.77% |
2011 Q4 | 2.66 Million AUD | 0.0% |
2011 FY | 2.66 Million AUD | -29.96% |
2010 Q4 | 3.79 Million AUD | 0.0% |
2010 FY | 3.79 Million AUD | 670.42% |
2009 FY | 493.02 Thousand AUD | -74.05% |
2009 Q4 | 493.02 Thousand AUD | 0.0% |
2008 FY | 1.89 Million AUD | -42.36% |
2008 Q4 | 1.89 Million AUD | 0.0% |
2007 Q4 | 3.29 Million AUD | 0.0% |
2007 FY | 3.29 Million AUD | -50.25% |
2006 Q4 | 6.62 Million AUD | 0.0% |
2006 FY | 6.62 Million AUD | -17.75% |
2005 FY | 8.05 Million AUD | 64.06% |
2005 Q4 | 8.05 Million AUD | 0.0% |
2004 Q4 | 4.9 Million AUD | 0.0% |
2004 FY | 4.9 Million AUD | 0.0% |
2002 Q4 | 6.57 Million AUD | 0.0% |
2002 FY | 6.57 Million AUD | -16.02% |
2001 Q4 | 7.83 Million AUD | 0.0% |
2001 FY | 7.83 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AdAlta Limited | 5.57 Million AUD | -179.023% |
Acrux Limited | 8.96 Million AUD | -73.491% |
Botanix Pharmaceuticals Limited | 112.46 Million AUD | 86.173% |
BTC Health Limited | 5.14 Million AUD | -202.011% |
Chimeric Therapeutics Limited | 15.27 Million AUD | -1.812% |
Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 89.944% |
Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 93.272% |
Biome Australia Limited | 8.27 Million AUD | -87.874% |
Hexima Limited | 2.26 Million AUD | -585.321% |
Immutep Limited | 147.44 Million AUD | 89.454% |
Memphasys Limited | 12.43 Million AUD | -25.099% |
Neuren Pharmaceuticals Limited | 247.97 Million AUD | 93.729% |
Noxopharm Limited | 6.78 Million AUD | -129.224% |
Prescient Therapeutics Limited | 20.39 Million AUD | 23.748% |
Race Oncology Limited | 20.22 Million AUD | 23.129% |
Radiopharm Theranostics Limited | 72.03 Million AUD | 78.414% |
Starpharma Holdings Limited | 36.81 Million AUD | 57.761% |
Tissue Repair Ltd | 19.38 Million AUD | 19.802% |
Biotron Limited | 493.47 Thousand AUD | -3051.109% |
Alterity Therapeutics Limited | 19.22 Million AUD | 19.111% |
CSL Limited | 56.93 Billion AUD | 99.973% |
EZZ Life Science Holdings Limited | 25.55 Million AUD | 39.144% |
Anatara Lifesciences Ltd | 1.67 Million AUD | -830.344% |
Bio-Gene Technology Limited | 3.15 Million AUD | -392.151% |
Zelira Therapeutics Limited | 5.18 Million AUD | -199.995% |
Patrys Limited | 4.16 Million AUD | -273.655% |
Orthocell Limited | 26.61 Million AUD | 41.575% |
Imugene Limited | 151.39 Million AUD | 89.729% |
PYC Therapeutics Limited | 91.23 Million AUD | 82.957% |
Proteomics International Laboratories Limited | 10.87 Million AUD | -42.987% |
Cynata Therapeutics Limited | 8.38 Million AUD | -85.377% |
Arovella Therapeutics Limited | 13.28 Million AUD | -17.052% |
Nanollose Limited | 241.95 Thousand AUD | -6326.908% |
Invex Therapeutics Ltd | 6.12 Million AUD | -154.082% |
NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -186.062% |
Amplia Therapeutics Limited | 14.84 Million AUD | -4.748% |
Island Pharmaceuticals Limited | 2.56 Million AUD | -506.362% |
Nyrada Inc. | 5.9 Million AUD | -163.235% |
Telix Pharmaceuticals Limited | 398.3 Million AUD | 96.096% |
Dimerix Limited | 32.07 Million AUD | 51.525% |
PharmAust Limited | 11.12 Million AUD | -39.777% |
AnteoTech Limited | 9.38 Million AUD | -65.757% |
Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 43.228% |
Recce Pharmaceuticals Ltd | 6.36 Million AUD | -144.127% |
Avecho Biotechnology Limited | 7.31 Million AUD | -112.451% |
Actinogen Medical Limited | 21.31 Million AUD | 27.036% |
Argenica Therapeutics Limited | 16.37 Million AUD | 5.053% |